Apolipoprotein E (APOE), PARKIN and catechol-O-methyltransferase (COMT) genes and susceptibility to sporadic Parkinson's disease in Finland

被引:40
作者
Eerola, J
Launes, J
Hellström, O
Tienari, PJ
机构
[1] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland
[2] Univ Helsinki, Biomedicum, Neurosci Programme C524, Helsinki, Finland
[3] Seinajoki Cent Hosp, Dept Neurol, Seinajoki, Finland
关键词
Parkinson's disease; gene studies; Finland;
D O I
10.1016/S0304-3940(02)00819-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent studies have demonstrated that genetic factors modify susceptibility to sporadic Parkinson's disease (PD). So far the results of candidate gene studies have been conflicting. It has been suggested that polymorphisms in apolipoprotein E (APOE), PARKIN and catechol-O-methyltransferase (COMT) genes might increase the risk of PD. We studied 147 Finnish non-demented patients with sporadic PD and 137 controls. APOEE allele and genotype frequencies in PD patients did not differ significantly from controls. Three single nucleotide polymorphisms of the PARKIN gene and an intronic and an exonic (Val158Met) polymorphism of the COMT gene were studied. None of these polymorphisms showed association with PD in our series. In contrast to reports in oriental populations, our results do not support a major role of APOE, PARKIN and COMT polymorphisms in PD susceptibility in the Finnish population. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:296 / 298
页数:3
相关论文
共 24 条
[1]  
EEROLA J, UNPUB GOOD IS 123I B
[2]   The heterogeneity of idiopathic Parkinson's disease [J].
Foltynie, T ;
Brayne, C ;
Barker, RA .
JOURNAL OF NEUROLOGY, 2002, 249 (02) :138-145
[3]   APOE and the risk of PD with or without dementia in a population-based study [J].
Harhangi, BS ;
de Rijk, MC ;
van Duijn, CM ;
Van Broeckhoven, C ;
Hofman, A ;
Breteler, MMB .
NEUROLOGY, 2000, 54 (06) :1272-1276
[4]   Apolipoprotein E polymorphism in patients with different neurodegenerative disorders [J].
Helisalmi, S ;
Linnaranta, K ;
Lehtovirta, M ;
Mannermaa, A ;
Heinonen, O ;
Ryynanen, M ;
Riekkinen, P ;
Soininen, H .
NEUROSCIENCE LETTERS, 1996, 205 (01) :61-64
[5]   No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase [J].
Hoda, F ;
Nicholl, D ;
Bennett, P ;
Arranz, M ;
Aitchison, KJ ;
AlChalabi, A ;
Kunugi, H ;
Vallada, H ;
Leigh, PN ;
Chaudhuri, KR ;
Collier, DA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 228 (03) :780-784
[6]   High and low activity alleles of catechol-O-methyltransferase gene: Ethnic difference and possible association with Parkinson's disease [J].
Kunugi, H ;
Nanko, S ;
Ueki, A ;
Otsuka, E ;
Hattori, M ;
Hoda, F ;
Vallada, HP ;
Arranz, MJ ;
Collier, DA .
NEUROSCIENCE LETTERS, 1997, 221 (2-3) :202-204
[7]  
Laihinen A, 2000, J NEUROL, V247, P110
[8]  
Maraganore DM, 2000, MOVEMENT DISORD, V15, P714, DOI 10.1002/1531-8257(200007)15:4<714::AID-MDS1018>3.0.CO
[9]  
2-3
[10]   Apolipoprotein E ε4 allele frequency is increased in Parkinson's disease only with co-existing Alzheimer pathology [J].
Mattila, PM ;
Koskela, T ;
Röyttä, M ;
Lehtimäki, T ;
Pirttila, TA ;
Ilveskoski, E ;
Karhunen, P ;
Rinne, JO .
ACTA NEUROPATHOLOGICA, 1998, 96 (04) :417-420